Transcode Therapeutics Inc RNAZ:NASDAQ

RT Quote | NASDAQ | USD
Last | 07/01/22 EDT
1.24quote price arrow down-0.02 (-1.59%)
Volume
1,740
52 week range
1.13 - 7.00
Loading...
  • Open1.26
  • Day High1.26
  • Day Low1.24
  • Prev Close1.26
  • 52 Week High7.00
  • 52 Week High Date07/09/21
  • 52 Week Low1.13
  • 52 Week Low Date06/30/22

Key Stats

  • Market Cap16.10M
  • Shares Out12.98M
  • 10 Day Average Volume0.06M
  • Dividend-
  • Dividend Yield-
  • Beta-
  • YTD % Change-51.18

KEY STATS

  • Open1.26
  • Day High1.26
  • Day Low1.24
  • Prev Close1.26
  • 52 Week High7.00
  • 52 Week High Date07/09/21
  • 52 Week Low1.13
  • 52 Week Low Date06/30/22
  • Market Cap16.10M
  • Shares Out12.98M
  • 10 Day Average Volume0.06M
  • Dividend-
  • Dividend Yield-
  • Beta-
  • YTD % Change-51.18

RATIOS/PROFITABILITY

  • EPS (TTM)-0.17
  • P/E (TTM)-7.16
  • Fwd P/E (NTM)-1.22
  • EBITDA (TTM)-9.121M
  • ROE (TTM)-
  • Revenue (TTM)0.00
  • Gross Margin (TTM)-
  • Net Margin (TTM)-
  • Debt To Equity (MRQ)0.00%

EVENTS

  • Earnings Date-
  • Ex Div Date-
  • Div Amount-
  • Split Date-
  • Split Factor-

Latest On Transcode Therapeutics Inc

There is no recent news for this security.

Profile

MORE
TransCode Therapeutics, Inc. is a biopharmaceutical company focused on developing and commercializing drugs for treating metastatic disease. The Company’s development pipeline includes TTX-MC138, TTX-siPD-L1 and TTX-RIGA, TTX-siLIN28B, and TCD-miR10b. The Company has developed a modular, iron oxide nanoparticle-based nanocarrier system for the delivery of RNA therapeutics to tumors. The Company’s lead therapeutic candidate, TTX-MC138, targets microRNA-10b (miRNA-10b), a...
Address
6 Liberty Square, #2382
Boston, MA
02109
United States